You are here

macular edema

Roche reports data from Phase III retinal vein occlusion therapy trials

Clinical Trials Arena

Thu, 02/1/24 - 11:15 am

central retinal vein occlusion

FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

BioSpace

Tue, 05/9/23 - 12:27 pm

retinal vein occlusion

Kodiak matches Regeneron’s Eylea in macular edema phase 3, lighting Beacon of hope after flop

Fierce Biotech

Tue, 08/9/22 - 06:34 am

Kodiak Sciences

clinical trials

AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis

Xconomy

Wed, 06/24/20 - 10:14 am

AsclepiX Therapeutics

wet age-related macular degeneration

retinal occulsion

Bayer's hot-selling Eylea runs into a roadblock in its home market

Fierce Pharma

Sat, 01/4/14 - 04:32 pm

Regeneron's Eylea Approved by Japanese Regulator

Motley Fool

Sat, 11/23/13 - 12:40 pm

Bayer receives new approval for Eylea eye treatment in Japan

Yahoo/Reuters

Fri, 11/22/13 - 08:29 am

Eylea Drives Regeneron

Yahoo/Zacks

Sat, 02/16/13 - 11:17 am

macular degeneration

2 Drug Approvals and Shares Drop? That's Biotech!

Motley Fool

Tue, 09/25/12 - 09:46 am

age-related macular degeneration

Takeda's Actos, Glaxo's Avandia Raise Risk of Eye Disease

San Francisco Gate, CA

Sat, 06/25/11 - 11:22 am

Genentech says Lucentis gets new FDA approval

Yahoo/AP

Wed, 06/23/10 - 09:14 am